Knowledge and Perception Towards Psychotropic Drugs Among the General Population in Saudi Arabia

Eatedal Al-Shareef,Alaa Kadah Salim,Nada Al-Farrah,Bader Al-Murad,Adnan Moallem,Mohammed Radwan,Salman Hakami,Asim Alshanberi,Mohammed Shaikhomer,Safaa Alsanosi

DOI: https://doi.org/10.2147/prbm.s485798

IF: 3.974

2024-10-16

Psychology Research and Behavior Management

Abstract:Eatedal M Al-Shareef, 1 Alaa M Kadah Salim, 1 Nada M Al-Farrah, 1 Bader M Al-Murad, 1 Adnan A Moallem, 1 Mohammed A Radwan, 1 Salman Hakami, 2 Asim M Alshanberi, 1, 3 Mohammed Shaikhomer, 4 Safaa M Alsanosi 5 1 General Medicine Program, Batterjee Medical College, Jeddah, 21442, Saudi Arabia; 2 Department of Psychiatry, Mental Health Hospital, Ministry of Health, Jeddah, Saudi Arabia; 3 Department of Community Medicine and Pilgrims Health Care, Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia; 4 Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 5 Department of Pharmacology and Toxicology Faculty of Medicine, Umm Al Qura University, Makkah, Saudi Arabia Correspondence: Safaa M Alsanosi, Email Background: Mental health is crucial to overall well-being. Despite an increase in mental disorders over the past few decades, public awareness remains slow-growing, and stigmatization towards psychotropic medications persists. Therefore, this study aimed to identify knowledge and perceptions of psychotropic drugs among the general population in the Makkah Region, Saudi Arabia. Methods: A questionnaire-based cross-sectional study was conducted among adults aged 18 years old and older, living in the Makkah Region, Saudi Arabia, from 1 January to 30 April 2024. Descriptive statistics were used to describe participants' characteristics, and categorical variables were reported as frequencies and percentages. A Chi-square test was used to examine the relationships between variables. Results: A total of 717 participants were involved in the study: (52%) were from Jeddah, (25.9%) were from Taif, and (22%) were from Makkah. The mean age was 33.9 years, and 67.1% were females. Among the participants, (20.8%) had experienced a psychiatric illness, (41.7%) had a member of the family who suffered from a psychiatric illness, (39.5%) had a family member who used a psychiatric drug, and only 25 (7%) had a child suffering from a psychiatric illness. Specifically, 20.8% of those with a psychiatric illness demonstrated good knowledge (P=0.001), 16.1% of those with a family history of psychiatric illness had good knowledge (P=0.007), 16.3% with family use of psychiatric drugs had good knowledge (P=0.006), and 24.5% of those who used psychiatric drugs had high knowledge (P=0.001). Overall, (40.6%) of participants had a low level of knowledge and perception about psychotropic drugs, (47.8%) had a moderate knowledge and perception level, and only (11.6%) had high knowledge and perception. Conclusion: Psychological well-being is crucial for health, but misconceptions persist, acting as barriers that impede people from seeking and accepting necessary psychiatric care. The findings highlight the need for targeted public education and healthcare professional training to improve Confirmed understanding and reduce stigma around psychotropic drugs in Saudi Arabia. A multifaceted approach involving policy development, community outreach, and ongoing research is essential for enhancing mental health outcomes and treatment accessibility. Keywords: knowledge, perception, psychotropic drugs, Saudi Arabia A comprehensive state of mental, social, and physical well-being is what the World Health Organisation (WHO) defines as health. One crucial component of health is mental wellness. 1 However, over the past ten years, there has been an increase in the prevalence of mental illnesses, which is now regarded as a public health issue. More than 970 million individuals worldwide have experienced mental health issues, making it the fifth leading cause of global disabilities. People with mental disorders have faced worsening mental health issues due to the COVID-19 epidemic. 2,3 For example, the prevalence of depression symptoms increased during the pandemic by more than threefold. Additionally, in primary healthcare facilities in Saudi Arabia, the prevalence of mental disorders is reported to be between 30% and 46%, with depression prevalence being around 20%. 4,5 Moreover, stigma was found to be positively correlated with a greater intention to use psychotropic medications, while perceived stigma was found to be negatively correlated with a desire to consult a psychotherapist. 6 The public typically holds stigmatizing and negative opinions about people with psychiatric problems and those who suffer from them. People's attitudes towards seeking treatment for psychiatric problems may be influenced by their fear of being stigmatized and shunned. 7 Furthermore, patients' negative perceptions and ideas abo -Abstract Truncated-

psychology, clinical, multidisciplinary